BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16122239)

  • 1. Tetrahydropyrido[3,4-b]pyrazine scaffolds from pentafluoropyridine.
    Sandford G; Slater R; Yufit DS; Howard JA; Vong A
    J Org Chem; 2005 Sep; 70(18):7208-16. PubMed ID: 16122239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyfunctional tetrahydropyrido[2,3-b]pyrazine scaffolds from 4-phenylsulfonyl tetrafluoropyridine.
    Baron A; Sandford G; Slater R; Yufit DS; Howard JA; Vong A
    J Org Chem; 2005 Nov; 70(23):9377-81. PubMed ID: 16268611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of pyridopyrazine-1,6-diones from 6-hydroxypicolinic acids via a one-pot coupling/cyclization reaction.
    Tran TP; Mullins PB; am Ende CW; Pettersson M
    Org Lett; 2013 Feb; 15(3):642-5. PubMed ID: 23330785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysubstituted pyridazinones from sequential nucleophilic substitution reactions of tetrafluoropyridazine.
    Pattison G; Sandford G; Yufit DS; Howard JA; Christopher JA; Miller DD
    J Org Chem; 2009 Aug; 74(15):5533-40. PubMed ID: 19518071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazoloheteroaryls: novel p38alpha MAP kinase inhibiting scaffolds with oral activity.
    Revesz L; Blum E; Di Padova FE; Buhl T; Feifel R; Gram H; Hiestand P; Manning U; Neumann U; Rucklin G
    Bioorg Med Chem Lett; 2006 Jan; 16(2):262-6. PubMed ID: 16249085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-pot synthesis of new A-ring fused steroidal pyridines.
    Yan JZ; Li J; Rao GW
    Steroids; 2007 Oct; 72(11-12):736-9. PubMed ID: 17686502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palladium-catalyzed direct heck arylation of dual pi-deficient/pi-excessive heteroaromatics. Synthesis of C-5 arylated imidazo[1,5-a]pyrazines.
    Wang JX; McCubbin JA; Jin M; Laufer RS; Mao Y; Crew AP; Mulvihill MJ; Snieckus V
    Org Lett; 2008 Jul; 10(14):2923-6. PubMed ID: 18576663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on pyrazine derivatives. XV. Synthesis and tuberculostatic effect of imidazoline pyrazines and imidazoline pyridines].
    Foks H; Janowiec M
    Acta Pol Pharm; 1982; 39(1-3):79-82. PubMed ID: 6817592
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and spectroscopic and electrochemical studies of pyrazine- or pyridine-ring-fused tetraazachlorins, bacteriochlorins, and isobacteriochlorins.
    Makarova EA; Dzyuina EV; Fukuda T; Kaneko H; Hashimoto N; Kikukawa Y; Kobayashi N; Lukyanets EA
    Inorg Chem; 2009 Jan; 48(1):164-73. PubMed ID: 19049420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new strategy toward fused-pyridine heterocyclic scaffolds: Bischler-Napieralski-type cyclization, followed by sulfoxide extrusion reaction.
    Xu X; Guo S; Dang Q; Chen J; Bai X
    J Comb Chem; 2007; 9(5):773-82. PubMed ID: 17658898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regioselective one-pot synthesis of 9-alkyl-6-chloropyrido[3,2-e][1,2,4]triazolo[4,3-a]pyrazines. Reactivity of aliphatic and aromatic hydrazides.
    Unciti-Broceta A; Pineda-de-las-Infantas MJ; Díaz-Mochón JJ; Romagnoli R; Baraldi PG; Gallo MA; Espinosa A
    J Org Chem; 2005 Apr; 70(7):2878-80. PubMed ID: 15787593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
    J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 3-aminopyrazinone mediated by 2-pyridylthioimidate-ZnCl2 complexes. Development of an efficient route to a thrombin inhibitor.
    Chung JY; Cvetovich RJ; Tsay FR; Dormer PG; DiMichele L; Mathre DJ; Chilenski JR; Mao B; Wenslow R
    J Org Chem; 2003 Nov; 68(23):8838-46. PubMed ID: 14604352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety.
    Gobis K; Foks H; Kedzia A; Wierzchowska M; Kwapisz E; Zwolska Z; Augustynowicz-Kopeć E
    Acta Pol Pharm; 2006; 63(1):39-45. PubMed ID: 17515328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound promoted facile synthesis of some pentafluoropyridine derivatives at ambient conditions.
    Ranjbar-Karimi R; Mashak-Shoshtari M; Darehkordi A
    Ultrason Sonochem; 2011 Jan; 18(1):258-63. PubMed ID: 20630789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild addition of nucleophiles to pyridine-N-oxides.
    Londregan AT; Jennings S; Wei L
    Org Lett; 2011 Apr; 13(7):1840-3. PubMed ID: 21375291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of pyrazine alcaloids from Botryllus leachi. Diazines 43.
    Buron F; Plé N; Turck A; Queguiner G
    J Org Chem; 2005 Apr; 70(7):2616-21. PubMed ID: 15787551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient synthesis of chromone and flavonoid derivatives with diverse heterocyclic units.
    Arai MA; Sato M; Sawada K; Hosoya T; Ishibashi M
    Chem Asian J; 2008 Dec; 3(12):2056-64. PubMed ID: 18830978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists.
    Boström J; Berggren K; Elebring T; Greasley PJ; Wilstermann M
    Bioorg Med Chem; 2007 Jun; 15(12):4077-84. PubMed ID: 17433696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general and efficient five-step one-pot procedure leading to nitrogen-bridgehead heterocycles containing an imidazole ring.
    Parenty AD; Song YF; Richmond CJ; Cronin L
    Org Lett; 2007 Jun; 9(12):2253-6. PubMed ID: 17500559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.